We retrospectively assessed the utility of a flow cytometry-based test quantifying the percentage of CD3+ T cells with the CD4-/CD8- phenotype for predicting tularemia diagnoses in 64 probable and confirmed tularemia patients treated during 2003-2015 and 342 controls with tularemia-like illnesses treated during 2012-2015 in the Czech Republic. The median percentage of CD3+/CD4-/CD8- T cells in peripheral blood was higher in tularemia patients (19%, 95% CI 17%-22%) than in controls (3%, 95% CI 2%-3%). When we used 8% as the cutoff, this test's sensitivity was 0.953 and specificity 0.895 for distinguishing cases from controls. The CD3+/CD4-/CD8- T cells increased a median of 7 days before tularemia serologic test results became positive. This test supports early presumptive diagnosis of tularemia for clinically suspected cases 7-14 days before diagnosis can be confirmed by serologic testing in regions with low prevalences of tularemia-like illnesses.

Zobrazit více v PubMed

McCoy GW, Chapin CW. Further observations on a plague-like disease of rodents with a preliminary note on the causative agent, Bacterium tularense. J Infect Dis. 1912;10:61–72. 10.1093/infdis/10.1.61 DOI

European Centre for Disease Prevention and Control. Tularaemia-annual epidemiological report 2016. 2019. Jan 22 [cited 2018 Dec 7]. https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2016-tularaemia.pdf

Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105:1–29. 10.1196/annals.1409.009 PubMed DOI

Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16:113–24. 10.1016/S1473-3099(15)00355-2 PubMed DOI

Yapar D, Erenler AK, Terzi Ö, Akdoğan Ö, Ece Y, Baykam N. Predicting tularemia with clinical, laboratory and demographical findings in the ED. Am J Emerg Med. 2016;34:218–21. 10.1016/j.ajem.2015.10.034 PubMed DOI

Tuncer E, Onal B, Simsek G, Elagoz S, Sahpaz A, Kilic S, et al. Tularemia: potential role of cytopathology in differential diagnosis of cervical lymphadenitis: multicenter experience in 53 cases and literature review. APMIS. 2014;122:236–42. 10.1111/apm.12132 PubMed DOI

Weber IB, Turabelidze G, Patrick S, Griffith KS, Kugeler KJ, Mead PS. Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases. Clin Infect Dis. 2012;55:1283–90. 10.1093/cid/cis706 PubMed DOI

Maurin M, Pelloux I, Brion JP, Del Banõ JN, Picard A. Human tularemia in France, 2006-2010. Clin Infect Dis. 2011;53:e133–41. 10.1093/cid/cir612 PubMed DOI

Chu M, Elkins K, Nano F, Titball R. Considerations for handling F. tularensis. In: Tärnvik A, editor. WHO guidelines on tularaemia. Geneva: World Health Organization; 2007. [cited 2018 Dec 7]. https://www.who.int/csr/resources/publications/WHO_CDS_EPR_2007_7.pdf?ua=1

Esin S, Shigematsu M, Nagai S, Eklund A, Wigzell H, Grunewald J. Different percentages of peripheral blood γ δ + T cells in healthy individuals from different areas of the world. Scand J Immunol. 1996;43:593–6. 10.1046/j.1365-3083.1996.d01-79.x PubMed DOI

Cairo C, Armstrong CL, Cummings JS, Deetz CO, Tan M, Lu C, et al. Impact of age, gender, and race on circulating γδ T cells. Hum Immunol. 2010;71:968–75. 10.1016/j.humimm.2010.06.014 PubMed DOI PMC

Bank I, Marcu-Malina V. Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications. Clin Rev Allergy Immunol. 2014;47:311–33. 10.1007/s12016-013-8391-x PubMed DOI

Cibulka M, Selingerová I, Fědorová L, Zdražilová Dubská L. Immunological aspects in oncology–circulating γδ T-cells [in Czech]. Klin Onkol. 2015;28(Suppl 2):S60–8. 10.14735/amko20152S60 PubMed DOI

Sumida T, Maeda T, Takahashi H, Yoshida S, Yonaha F, Sakamoto A, et al. Predominant expansion of V γ 9/V δ 2 T cells in a tularemia patient. Infect Immun. 1992;60:2554–8. PubMed PMC

Kroca M, Tärnvik A, Sjöstedt A. The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year. Clin Exp Immunol. 2000;120:280–4. 10.1046/j.1365-2249.2000.01215.x PubMed DOI PMC

Chen ZW, Letvin NL. Vgamma2Vdelta2+ T cells and anti-microbial immune responses. Microbes Infect. 2003;5:491–8. 10.1016/S1286-4579(03)00074-1 PubMed DOI PMC

Tsukaguchi K, Balaji KN, Boom WH. CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J Immunol. 1995;154:1786–96. PubMed

Kroca M, Johansson A, Sjöstedt A, Tärnvik A. V γ 9V δ 2 T cells in human legionellosis. Clin Diagn Lab Immunol. 2001;8:949–54. PubMed PMC

Hara T, Mizuno Y, Takaki K, Takada H, Akeda H, Aoki T, et al. Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest. 1992;90:204–10. 10.1172/JCI115837 PubMed DOI PMC

Bertotto A, Gerli R, Spinozzi F, Muscat C, Scalise F, Castellucci G, et al. Lymphocytes bearing the γ δ T cell receptor in acute Brucella melitensis infection. Eur J Immunol. 1993;23:1177–80. 10.1002/eji.1830230531 PubMed DOI

Kilic SS, Akbulut HH, Ozden M, Bulut V. Gamma/delta T cells in patients with acute brucellosis. Clin Exp Med. 2009;9:101–4. 10.1007/s10238-008-0021-1 PubMed DOI

Caldwell CW, Everett ED, McDonald G, Yesus YW, Roland WE. Lymphocytosis of γ/δ T cells in human ehrlichiosis. Am J Clin Pathol. 1995;103:761–6. 10.1093/ajcp/103.6.761 PubMed DOI

Schneider T, Jahn HU, Liesenfeld O, Steinhoff D, Riecken EO, Zeitz M, et al. The number and proportion of Vgamma9 Vdelta2 T cells rise significantly in the peripheral blood of patients after the onset of acute Coxiella burnetii infection. Clin Infect Dis. 1997;24:261–4. 10.1093/clinids/24.2.261 PubMed DOI

Scalise F, Gerli R, Castellucci G, Spinozzi F, Fabietti GM, Crupi S, et al. Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis. Immunology. 1992;76:668–70. PubMed PMC

Russo DM, Armitage RJ, Barral-Netto M, Barral A, Grabstein KH, Reed SG. Antigen-reactive gamma delta T cells in human leishmaniasis. J Immunol. 1993;151:3712–8. PubMed

Perera MK, Carter R, Goonewardene R, Mendis KN. Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms. J Exp Med. 1994;179:311–5. 10.1084/jem.179.1.311 PubMed DOI PMC

Schwartz E, Rosenthal E, Bank I. Gamma delta T cells in non-immune patients during primary schistosomal infection. Immun Inflamm Dis. 2014;2:56–61. 10.1002/iid3.18 PubMed DOI PMC

Bártová V, Žampach P. Certain immune parameters in tularemia [in Czech]. Klin Mikrobiol Infekc Lek. 2000;6: 77–8.

Mailles A, Vaillant V. 10 years of surveillance of human tularaemia in France. Euro Surveill. 2014;19:20956. 10.2807/1560-7917.ES2014.19.45.20956 PubMed DOI

Erdem H, Ozturk-Engin D, Yesilyurt M, Karabay O, Elaldi N, Celebi G, et al. Evaluation of tularaemia courses: a multicentre study from Turkey. Clin Microbiol Infect. 2014;20:O1042–51. 10.1111/1469-0691.12741 PubMed DOI

Centers for Disease Control and Prevention. Tularemia (Francisella tularensis). 1999 case definition. [cited 2018 Aug 29]. https://wwwn.cdc.gov/nndss/conditions/tularemia/case-definition/1999

Centers for Disease Control and Prevention. Tularemia (Francisella tularensis). 2017 case definition. [cited 2018 Aug 29]. https://wwwn.cdc.gov/nndss/conditions/tularemia/case-definition/2017

Rådström P, Bäckman A, Qian N, Kragsbjerg P, Påhlson C, Olcén P. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J Clin Microbiol. 1994;32:2738–44. PubMed PMC

Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5. 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 PubMed DOI

Poquet Y, Kroca M, Halary F, Stenmark S, Peyrat MA, Bonneville M, et al. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect Immun. 1998;66:2107–14. PubMed PMC

Bulut OC, Dyckhoff G, Splettstoesser W, Nemeth J, Klauschen F, Penzel R, et al. Unmasked: when a clinically malignant disease turns out infectious. A rare case of tularemia. Int J Surg Pathol. 2013;21:76–81. 10.1177/1066896912448424 PubMed DOI

Hviid L, Akanmori BD, Loizon S, Kurtzhals JA, Ricke CH, Lim A, et al. High frequency of circulating γ δ T cells with dominance of the v(δ)1 subset in a healthy population. Int Immunol. 2000;12:797–805. 10.1093/intimm/12.6.797 PubMed DOI

Cerný Z. Changes of the epidemiology and the clinical picture of tularemia in Southern Moravia (the Czech Republic) during the period 1936-1999. Eur J Epidemiol. 2001;17:637–42. 10.1023/A:1015551213151 PubMed DOI

Strålin K, Eliasson H, Bäck E. An outbreak of primary pneumonic tularemia. N Engl J Med. 2002;346:1027–9, author reply 1027–9. 10.1056/NEJM200203283461316 PubMed DOI

Pérez-Castrillón JL, Bachiller-Luque P, Martín-Luquero M, Mena-Martín FJ, Herreros V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis. 2001;33:573–6. 10.1086/322601 PubMed DOI